Indication for increasing prevalence of resistance mutations for protease inhibitors in therapy-naive HIV-1-positive German patients.
Dietrich
U
U
Raudonat
I
I
Wolf
E
E
Jäger
H
H
Husak
R
R
Orfanos
C E
CE
Knickmann
M
M
Knechten
H
H
von Briesen
H
H
Ruppach
H
H
Immelmann
A
A
D019380:Anti-HIV Agents / Q000494:pharmacology / Q000627:therapeutic use; D004352:Drug Resistance, Microbial / Q000235:genetics; D005858:Germany; D015658:HIV Infections / Q000188:drug therapy* / Q000208:ethnology / Q000821:virology*; D017320:HIV Protease Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D015497:HIV-1 / Q000187:drug effects* / Q000235:genetics; D006801:Humans; D009154:Mutation
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors